Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Benoit

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Gynecologic Oncology|December 13, 2024
Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trialHenri Azaïs, Camille Brochard, Valérie Taly, et al.
Cancers|February 11, 2023
A Suggested Modification to FIGO Stage IV Epithelial Ovarian CancerMarie Métairie, Louise Benoit, Meriem Koual, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|May 11, 2023
Prognostic impact of cytoreductive surgery conducted with primary intent, versus cytoreductive surgery after neoadjuvant chemotherapy, in the management of patients with advanced epithelial ovarian cancers: a multicentre, propensity score-matched study from the FRANCOGYN groupHenri Wohrer, Meriem Koual, Enrica Bentivegna, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Gynecologic Oncology|December 13, 2024
Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trialHenri Azaïs, Camille Brochard, Valérie Taly, et al.
Cancers|February 11, 2023
A Suggested Modification to FIGO Stage IV Epithelial Ovarian CancerMarie Métairie, Louise Benoit, Meriem Koual, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|May 11, 2023
Prognostic impact of cytoreductive surgery conducted with primary intent, versus cytoreductive surgery after neoadjuvant chemotherapy, in the management of patients with advanced epithelial ovarian cancers: a multicentre, propensity score-matched study from the FRANCOGYN groupHenri Wohrer, Meriem Koual, Enrica Bentivegna, et al.
Pageof 5